Introduction
Wheat forms the basis of a diverse range of staple foods globally, which includes bread and bakery items in addition to other products such as alcoholic beverages and food additives. Two major storage protein families are present in wheat grains: glutenins and gliadins (belonging to glutelins and prolamins, respectively), which are collectively known as gluten. The qualitative and quantitative properties of wheat gluten are important factors for baking quality. Despite its predominance in the human diet, wheat can cause allergies and/or intolerances after consumption in susceptible individuals (Fasano, 2006) . Wheat contains immunogenic proteins, but the prevalence of wheat allergy, which is mediated by IgE antibodies, is low (Zuidmeer et al., 2008; Gilissen, van der Meer, and Smulders, 2014) . However, gluten can also trigger intolerance reactions in 1-2% of the human population, the most common of which is coeliac disease (CD) (Mäki et al., 2003; Rewers, 2005; Catassi, Gatti, and Fasano, 2014; Vriezinga, Schweizer, Koning, and Mearin, 2015) .
CD is a chronic inflammation of the small intestine, which leads to a variety of symptoms that can include malnutrition, bowel disorders, skin, bone, nerve, and muscle problems. It is induced by epitopes (peptide sequences of nine amino acids) present in gluten proteins from wheat, barley and rye. These epitopes are bound by human leucocyte antigen sub-units (HLA-DQ2 or HLA-DQ8) located on antigen presenting cells in humans, which are subsequently recognized by T cells, triggering an immune reaction (for reviews see Fasano, 2009; Koning, 2012) . CD develops in genetically predisposed individuals, and is induced by gluten ingestion. A strict gluten-free diet is currently the only treatment to stop the immune reaction and inflammation, allowing the intestine to recover, after which the symptoms gradually disappear.
Avoiding consumption of gluten is difficult to do in practice, due to the presence of wheat derivatives in many supermarket products (Atchison, Head, and Gates, 2010) . Therefore there is a need for new strategies to create food products with low gluten immunogenicity.
Here, we summarise several strategies to decrease wheat gluten toxicity for CD patients, based on food processing and on wheat breeding (Fig. 1) . The food processing strategies aim at removing gliadins or whole gluten from edible products (Gilissen et al. 2016b ) whereas the wheat breeding strategies focus on the removal of immunogenic epitopes from the gluten proteins, while potentially maintaining their food-technological properties (Smulders et al., 2015; Shewry and Tatham, 2016) . If successful, the latter strategy may result in food products considered coeliac-safe, despite containing large amounts of gluten, which would require alternative labelling from the term 'glutenfree'. A comparison of the applicability of these approaches, in terms of technical and economic aspects, is presented. Two groups of people may benefit especially from food products derived from such reduced CD-immunogenic wheat: (1) individuals suffering from CD, whether they are already or not yet diagnosed as CD patient, and (2) genetically predisposed individuals who may develop CD after prolonged wheat or gluten consumption.
Food processing-related strategies to manufacture gluten-free products or to lower the content of CD epitopes
Wheat gluten is a polymer composed of two types of proteins: glutenins and gliadins. The type of HMW subunits and the ratio of glutenins and gliadins determine the viscoelasticity properties required for bread, cakes or other baking products (Weegels, van de Pijpekamp, Graveland, Hamer, and Schofield, 1996; Shewry et al., 2009) . The high and low molecular weight glutenin subunits (HMW-glutenins and LMW-glutenins) form a strong glutenin macro polymer (GMP) network, formed by inter-chain disulphide bonds, which determines dough elasticity. The monomeric gliadin proteins (α/β-gliadins, γ-gliadins and ω-gliadins) are linked to the GMP and can be envisaged to 'dilute' the strength of the GMP, thus influencing dough viscosity (Shewry, 2009) . The glutenins are the less immunogenic gluten proteins for CD. The monomeric gliadin proteins (α/β-gliadins, γ-gliadins and ω-gliadins) are the most immunogenic.
Two types of products can be generated during food production: gluten-free products made without ingredients from wheat, barley or A. Jouanin et al. Food Research International xxx (xxxx) xxx-xxx rye (Fig. 1a) , or products with low gluten immunogenicity based on the processing of these cereal grains to remove the immunogenic gluten fraction (Fig. 1b) (as reviewed by Kucek, Veenstra, Amnuaycheewa, and Sorrells, 2015) . Food products can be labelled as 'gluten-free' as long as they contain < 20 ppm of gluten (Saturni, Ferretti, and Bacchetti, 2010) .
2.1. Gluten-free products made without ingredients from wheat, barley and rye
With increasing numbers of patients with CD being diagnosed, the gluten-free market is becoming more important, and gluten-free products are increasingly found on grocery shop shelves. Such products generally do not contain any wheat, barley or rye, but include several additives (Fig. 1a) to recreate the viscoelastic properties of gluten present in these cereal grains (as summarised by Gustafson, 2016) .
Current composition of gluten-free products
Currently commercial gluten-free bread is usually made from a mixture of flours, including maize, rice, sorghum and oat. Oat can be consumed safely by CD patients without a daily limit (Kaukinen, Collin, Huhtala, and Mäki, 2013; Hardy, Tye-Din, and Stewart, 2015; Gilissen et al., 2016a and references therein). Alternatively, flour from pseudocereals (such as amaranth, buckwheat and quinoa), legumes and nuts have been proposed as new candidates for gluten-free products.
Issues encountered with these gluten-free flours are their lack of viscoelasticity and their low ability to retain water and CO 2 , the properties responsible for dough rising conferred by the gluten network. Starch may be added to increase viscosity and provide some binding abilities to the dough (Horstmann et al., 2016) . Starches from potato, corn, rice and cassava (tapioca) are mostly used. Hydrocolloids, also known as gums, are also important additives in gluten-free baking products. They are used as substitute for glutenins to confer elasticity to the dough, as well as gas and moisture retention for higher loaf volumes and longer shelf life. Inulin, xanthan, guar gum, and hydroxypropyl methylcellulose (HPMC) are the most commonly used hydrocolloids in gluten-free bread. Protein concentrates such as soybean, egg and whey proteins are also used for their gelling properties, contributing to dough quality improvement. The addition of lipids, such as sunflower and safflower oil, retards the staling process, due to the gas-retaining properties of polar lipids (Hardy et al., 2015) . Additionally, emulsifiers such as glycerol monostearate and lecithin are commonly used to reduce staling and to increase shelf-life. High salt content is often used to improve taste, texture and bread stability (Belz, 2016) . The addition of dietary fibre through incorporation of oat or rice bran could become a solution to compensate for the low fibre content of gluten-free bread (Gilissen et al. 2016b) . Rice bran also appears to improve rheology and sensory aspects of gluten-free bread, whereas dough acidification with acetic, citric, or lactic acid, or monosodium phosphate can also help improve bread volume.
Health issues associated with current gluten-free products
Gluten-free bread thus contains far more additives than standard wheat bread. As a result, regular consumption of gluten-free bread may in itself cause health issues, e.g. the mineral content can be very low, leading to iron and calcium deficiency, and despite the inclusion of protein additives for dough improvement, it is a relatively poor source of protein. Gluten-free bread is usually low in fibre, which decreases the sensation of satiety; in contrast, it is rich in starch, thereby enhancing the risk of hyperglycaemia and diabetes. The high level of salt in glutenfree bread is a risk for cardiovascular and renal disease. In addition to being high in lipids, gluten-free products contain trans fatty acids, which may provoke metabolic imbalance (Caponio, Summo, Clodoveo, and Pasqualone, 2008) . Several countries try to reduce or eliminate them from food products. Fructan-type inulin is used in gluten-free bread as a hydrocolloid but is known to be a possible cause of irritable bowel syndrome (IBS) (Capriles and Arêas, 2014) . IBS is mainly caused by fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) such as fructan, a fructose polymer. Since fructans are present in the wheat grain, IBS is often associated with wheat as non-coeliac gluten sensitivity or non-coeliac wheat sensitivity (NCGS), and is sometimes wrongly auto-diagnosed as CD. While a low FODMAPs diet will usually decrease IBS symptoms, some gluten-free bread products containing inulin may not be suitable for these patients. In such cases, it is important to be diagnosed with the correct disorder. Nonetheless, based on the frequency of people with clinical bowel complaints that appear to improve under a gluten-free diet, the prevalence of NCGS might be as high as 6% of the population , but more recent evidence suggests that 'true' NCGS is only slightly > 1% of the population (Catassi, 2015) . Although no biomarkers have been identified yet, a state of systemic immune activation in conjunction with a suggested compromised intestinal epithelium could be observed in a subset of individuals with NCGS (Uhde et al., 2016) . In addition to individuals diagnosed with CD or IBS, other consumers have actively decided to avoid wheat and gluten based on personal choice. However, such choices are often made following self-diagnosis based on personal health-related preference, rather than for clear medical reasons, despite the dietary concerns described above.
Gluten contamination elimination diet (GCED)
Some coeliac patients have persistent symptoms and villous atrophy despite strict adherence to a gluten-free diet. They are referred to as having 'non-responsive CD'. Some non-responding CD patients may react to minute amounts of gluten, likely present as contaminants in processed gluten-free foods. For example, industrial conversion of wheat starch into other food-grade carbohydrates may not eliminate all gluten (Scherf, Wieser, and Koehler, 2016) . Therefore, foods containing these modified carbohydrates may still contain very low levels of stable, and potentially immunogenic, gluten. Furthermore, when chemically deamidated gluten protein, which is even more immunogenic than natural gluten proteins, is used for increased emulsifying applications (Wu, Nakai, and Powrie, 1976) it may be undetectable in the R5 monoclonal antibody assay used for routine gluten screening by commercial companies (Kanerva, Brinck, SontagStrohm, Salovaara, and Loponen, 2011) . These undetected deamidated gluten fractions can also contribute to contamination of food labelled as 'gluten-free'.
Over 80% of the non-responsive patients showed health improvement under a 'gluten contamination elimination diet' (GCED), that includes only fresh and unprocessed foods. These patients were able to return to a traditional gluten-free diet without return of symptoms (Hollon et al., 2015) . A subset of 'non-responsive CD' patients do not show any decrease in symptoms under GCED, and therefore suffer from true 'refractory CD' (RCD).
Development of wheat-based products with low gluten immunogenicity
Due to the low dietary value and health risks associated with nonwheat based gluten-free products, alternative food processing methods for wheat are being investigated (Fig. 1b) . The main aim is to use wheat (conserving the rheological properties conferred by the glutenins), while removing the most immunogenic gluten fraction (the gliadins). This approach would decrease the need for additives to reach adequate dough quality and dietary values, thus improving the healthiness of gluten-free or 'gluten-safe' products.
Malting
The malting process is not only relevant for brewing beer, but also for the baking sector. Malting represents the first step in seed germination, during which amylase enzymes become active, degrading starch into maltose to provide the source of energy for the embryo to germinate. Malting produces higher amounts of maltose, which en-A. Jouanin et al. Food Research International xxx (xxxx) xxx-xxx hances further fermentation. In addition, endogenous proteolytic enzymes in the grain degrade storage proteins (i.e. gluten), releasing amino acids that are used by the growing seedling. Gliadins become degraded through the activity of proteases (Bigiarini et al., 1995) . Because of this degradation process, in practice many brands of beer are technically gluten-free or contain only small amounts of gluten. Malting has been used for many years to add flavour and crust colour to bread, and can even enhance sourdough fermentation when the malting process is not fully stopped. It has been shown that malted and fermented wheat sourdough effectively degrade 95% of the gliadins (Loponen, Sontag-Strohm, Venäläinen, and Salovaara, 2007) , leading to bread that is low in gliadins. An alternative approach is the use of enzyme extracts from a small stock of germinated seeds (particularly barley seeds). This has recently been suggested to be applicable to the large-scale production of flour with a reduced gliadin content (Stenman et al., 2010; Schwalb, Wieser, and Koehler, 2012) .
Sourdough fermentation and dough acidification
Sourdough is the result of the activity of micro-organisms (Lactobacilli and yeast) naturally present in flour, becoming active when water is added. Lactobacillus ferments the flour/water mixture creating lactic acid, acidifying the mixture. This enhances the activity of propyl endopeptidase (PEP) enzymes produced by other micro-organisms to degrade gluten proteins (Hartmann, Koehler, and Wieser, 2006; Gänzle, Loponen, and Gobbetti, 2008; Loponen et al., 2009) . Sourdough fermentation has been suggested as a way of enabling the manufacture of gluten-free or 'low-in-gluten' (< 100 ppm) wheat-based products through proteolytic gluten degradation (Loponen, 2006) . Similarly, chemical acidification of conventional dough has been shown to activate PEP activity, resulting in increased prolamin degradation (Kanerva et al., 2011) , although not as much as in traditional sourdough. However, artificially acidified dough may trigger more intestinal permeability (Di Cagno et al., 2004) and enhance nonenzymatic deamination of gluten peptides, which may render them more immunogenic (Arentz-Hansen et al., 2000) .
Sourdough fermentation is a traditional baking process with a long history, particularly in Germany. The prevalence of CD in Germany (measured using a single antibody test) has been found to be remarkably low, 0.4% and 0.2% in women and men, respectively (Kratzer et al., 2013) , confirming earlier data showing a 0.1-0.4% prevalence on the basis of anti-tTG and anti-endomysial antibody (EMA-IgA) tests (Mustalahti et al., 2010) . Recent estimations of the celiac prevalence in Germany have increased to 0.8%, especially in children and young adults up to 17 years old (Laass et al., 2015) . This may reflect underdiagnosis in earlier studies. However, if sourdough indeed reduces the exposure to intact gluten epitopes, then the recent increase in CD prevalence in young people may reflect a change in the diet of German children towards white and yeast-based bread.
Recently, Greco et al. (2011) described a two-step hydrolysis including fungal proteases and Lactobacillus endo-peptidase activity, which resulted in a wheat flour-derived product with < 10 ppm gluten. This product was found not to be harmful to CD patients (Greco et al., 2011) . These observations are promising, but further research on the potential of sourdough products in a safe 'gluten-free' diet is needed, examining individual cases. Firstly, a strict definition on the type of sourdough is required, and the process of gluten degradation needs to be analysed in detail. Secondly, it needs to be determined whether large-scale consumption by the general population of well-defined sourdough products can indeed contribute to the reduction of the incidence and symptom severity of CD and NCWS. This will require large-scale epidemiological studies.
Degradation of gluten using a peptidase
Walter, Wieser, and Koehler (2014) showed that AN-PEP, an Aspergillus niger prolyl endopeptidase, can be used to degrade gluten in wheat bran to below 20 ppm. Such treated wheat bran could have a use in increasing the nutritional value of the gluten-free diet, e.g. by increasing soluble fibre content.
Separation of gliadins from total gluten
Extraction of HMW-glutenins from total gluten and substitution of the highly immunogenic wheat gliadins with, for instance, coeliac-safe oat avenins in order to maintain good baking quality (van den Broeck, Gilissen, Smulders, van der Meer, and Hamer, 2011) , is a realistic option in foods aiming at a strongly reduced immunogenic gluten load. Nearly complete separation can be achieved at the lab scale (Bassi, Maningat, Chinnaswamy, Gray, and Nie, 1997; Gilissen et al., 2012; Lagrain, Brunnbauer, Rombouts, and Koehler, 2013) . Industrial scaleup to economically and technologically viable levels appears to be more problematic, and would need further research. Alternatively, α-gliadins, the most immunogenic gluten proteins, can be partially removed mechanically using roller-milling to remove the seed sub-aleurone layer, in which a large fraction of the α-gliadins are deposited (van Herpen et al., 2008; Sutton, Simmons, Cummack, and Roberts, 2015) .
Reduction of the use of vital gluten
Vital (or purified) wheat gluten is a major side-product of wheat starch production. Starch is used to make native and modified starch, glucose syrup, maltodextrins, and liquid and crystalline polyols, with wide applications in the food industry. Wheat starch is also used for the production of alcohol, including bioethanol. Since wheat starch is economically more important than flour for bakery purposes, vital gluten production (as side-product of starch isolation) is large, and its cost relatively low.
Vital gluten is increasingly applied as a protein additive in food products to improve technological characteristics. In bread and bakery products vital gluten is added to maintain high loaf volumes, but most of its use is in the form of a 'hidden' ingredient, often not labelled, in a large number of processed food products. This may have contributed to the increase in total gluten consumption: between 1977 and 2007, gluten intake in the western world has tripled (Kasarda, 2013) . Currently, a 'back to basics' philosophy in modern bakeries in The Netherlands has led to 'clean label' strategies, and avoidance (or strong reduction) of bread quality-improving ingredients such as enzymes and vital gluten in artisanal and industrial whole grain breads. There is, however, no indication of a reduction in the use of vital gluten in other food production sectors.
3. Wheat breeding strategies for products with low gluten immunogenicity ('coeliac-safe wheat') An alternative strategy for the production of gluten-free wheatbased food is to develop wheat varieties with fewer or no immunogenic CD epitopes (Fig. 1c) (Gilissen, van der Meer, and Smulders, 2008; Shewry and Tatham, 2016) . To be able to generate such varieties, one must be aware of the complexity of wheat genome and the structure of gene families coding for gliadin immunogenic CD epitopes.
Wheat breeding background: genomics, gluten gene families and gliadin protein epitopes
The ancestor of all wild and cultivated wheat species was a diploid grass (2n = 14), which evolved into several diploid species (e.g. Goncharov, 2011; Goryunova et al., 2012) . Natural allopolyploidisation occurred through hybridisation between the diploid species Triticum urartu (AA genome) and Aegilops speltoides (BB or SS) followed by chromosome doubling, resulting in tetraploid emmer wheat, T. turgidum spp. dicoccoides (AABB). Much later, tetraploid emmer hybridized with goat grass, Aegilops tauschii (DD), followed by chromosome doubling, resulting in hexaploid bread wheat, Triticum aestivum (AABBDD) (Gupta, Mir, Mohan, and Kumar, 2008) . The latter allopolyploidisation took place in agricultural fields early after the start of cultivation of A. Jouanin et al. Food Research International xxx (xxxx) xxx-xxx emmer wheat. Bread wheat does not occur in nature. The α-gliadins are encoded by a large gene family of perhaps 150 genes, located on the short arms of the group 6 chromosomes (6AS, 6BS and 6DS) (Shewry, Halford, and Lafiandra, 2003) . The γ-gliadins, ω-gliadins and LMW-glutenins are encoded by gene families located on the short arms of the group 1 chromosomes (1AS, 1BS and 1DS), while the HMW-glutenins are encoded by gene families located on 1AL, 1BL and 1DL.
The presence of the D genome in hexaploid T. aestivum provides additional gluten proteins, which considerably improve its bread baking properties compared to tetraploid wheat, particularly HMWglutenin subunits (Payne, Jackson, and Holt, 1984) . However, the D genome also encodes for gliadins that have been reported as highly immunogenic.
CD epitopes are 9 amino acids in length, and form the peptide fragment that fits into the T cell HLA-DQ2 and HLA-DQ8 epitopepresenting receptor grooves. The list of well-defined CD epitopes (Sollid, Qiao, Anderson, et al., 2012) comprises: twenty-four DQ2 epitopes and seven DQ8 epitopes, including six epitopes present in α-gliadins and eleven in γ-gliadins, complemented by two ω-gliadin epitopes, three LMW-glutenin, and two HMW-glutenin epitopes. The HLA-DQ8 epitopes play a minor role in the development of CD, since over 90% of CD patients are HLA-DQ2 positive and react to α-gliadins (Koning, 2012 (Koning, , 2015 . The HLA-DQ/gliadin peptide/T cell interactions have been characterised extremely well. The positions that are crucial for immune reactivity of α-gliadins, identified by T cell tests (e.g., Mitea et al., 2010) , correspond exactly with the amino acid residues that form the crucial hydrogen bridges that connect HLA-DQ2 (Petersen et al., 2014) to the T cell receptor, a connection which, if sufficiently stable, triggers the immune reaction in humans. The structure of the HLA-DQ8/gliadin peptide/T cell interaction has also been characterised in detail (Petersen et al., 2016) .
At the genomic level, the occurrence of CD epitopes varies between gliadin genes (each locus comprising multiple gene copies), between homoeologous wheat chromosomes (A, B, D), and among wheat varieties and species (Spaenij-Dekking et al., 2005; Molberg et al., 2005; van Herpen et al., 2006; Salentijn et al., 2009; van den Broeck, de Jong, et al., 2010; van den Broeck, Hongbing, et al., 2010; van den Broeck et al., 2015) . The α-gliadins from the D genome contribute most CD epitopes, while those from the B genome contribute the least (van Herpen et al., 2006; Salentijn et al., 2009 ). For γ-gliadins, the highest number of CD epitopes has also been found in genes present on the D genome Salentijn et al., 2013) . While less sequence information is available for ω-gliadins, their involvement in CD immunogenicity has been recently recognized from cross-reactivity of T cells with rye and barley epitopes (Tye-Din et al., 2010) .
We will first discuss research approaches aimed at identifying naturally occurring variation within gliadin gene sequences and loci. This genetic variation can be used in conventional breeding and forward genetics approaches, by introgression into new wheat varieties. However, there is limited prospect for success, as multiple gliadin loci occur in the polyploid wheat genome, and glutenins and gliadins are encoded by large gene families, so multiple genes need to be screened. Many of the genes are closely linked in the genome, which limits the frequency of recombination, making selection of appropriate variation through a breeding approach difficult. Therefore, the use of reverse genetics approaches, such as random mutagenesis and transgenic methods (such as gene silencing) or gene editing are considered attractive options to create wheat varieties with reduced gluten immunogenicity. We will discuss such approaches later in this review.
When these approaches lead to wheat varieties with fewer gliadin proteins, this may affect baking quality. The effect should be compensated for, and one approach is the addition of celiac-safe proteins that perform the same function in the GMP , Smulders et al., 2015 , as was demonstrated for oat avenins added to flour of wheat deletion lines lacking certain groups of gliadins ).
Selection of low CD-toxic wheat accessions and varieties
Genebanks around the world contain modern and old varieties of hexaploid and tetraploid wheat varieties, as well as landraces (locally adapted wheat accessions), wild emmer (Triticum dicoccoides) and wild diploid species that are related to the ancestors of cultivated wheat (crop wild relatives). These collections are a useful source of wheat germplasm for analysing the relationships between individual gluten genes or proteins, the occurrence of epitope variants, and the resulting CD immunogenicity.
While there is large variation in the presence of intact CD epitopes among individual α-gliadin genes, all wheat varieties or accessions express multiple gliadins , which reduces the variation detected between varieties by immunogenic screening approaches. Indeed, screening with monoclonal antibodies (mAbs) for two CD epitopes revealed limited genetic variation in gliadins immunogenicity among modern wheat varieties (van den Broeck, de Jong, et al., 2010) . Some older hexaploid wheat varieties were identified with somewhat lower mAb response, as well as two lines derived from a heterogeneous tetraploid durum wheat landrace (van den Broeck, Hongbing, et al., 2010) . In addition, analysis of nine landraces of farro wheat (T. turgidum ssp. dicoccum) revealed three landraces that caused negligible proliferation of T-cell lines from CD patients, whereas the other landraces studied showed intermediate to very high responses (Vincentini et al., 2009) .
Diploid einkorn wheat (T. monococcum, A genome) has good nutritional characteristics and bread making quality. Food products made from the variety 'Monlis' have been shown to be tolerated by CD patients, revealing similar absence of CD toxicity-related symptoms as found for rice (Zanini et al., 2013) . New combinations of gluten genes can be made by crossing and selection at the diploid level. Although this is a time-consuming procedure, the increasing incidence of CD in recent decades would justify selection for reduced CD epitopes levels as a novel quality trait for wheat breeding (van den Broeck et al., 2011) .
The utility of screening wheat germplasm using epitope-specific mAbs is, however, limited. The specificity of mAbs is not exactly the same as that of the T cell epitopes, as mAbs only recognise peptide sequences of 4-6 amino acids in length, which is substantially shorter than the 9 amino acid T cell epitopes that cause CD (Londono et al., 2013) . Therefore, the identification of wheat genotypes with reduced CD toxicity using mAbs should be regarded as a preliminary screen, to be followed by screening of selected lines with more accurate methods. Salentijn et al. (2013) have examined the CD immunogenic potential of tetraploid durum wheat by deep sequencing of α-gliadin transcripts, including the sequences coding for both the N-terminal domain and the repetitive domain, where the CD epitopes occur, from developing grains. They found differences among varieties, but no variety was identified as safe for CD patients. Dubois, Bertin, and Mingeot (2016) screened spelt lines by sequencing α-gliadin genes expressed in the developing grains. They saw no clear separation in the occurrence of epitopes between spelt and bread wheat accessions, although some spelt lines expressed more B-genome α-gliadins, which contain fewer epitopes.
A direct approach would be to use quantitative proteomics to identify the gliadins in mature grains, as this would determine the exact amino acid sequence and the quantity of the proteins produced during grain development. However, this is complicated by the diversity of gluten genes in any single wheat variety, and the relative insensitivity of these proteins to the proteolysis step necessary for analysis. A method has recently been developed that enables identification and quantification of specific CD-epitopes in chymotryptic gluten digests (Dubois et al., 2016) .
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Reconstituting hexaploid bread wheat: synthetic hexaploids
Overall, the genetic variation of the D genome in hexaploid bread wheat is much lower than the genetic variation present in the A and B genomes. This is consistent with the theory that the hybridisation that led to hexaploid bread wheat resulted in a strong genetic bottleneck (Reif et al., 2005; Jones et al., 2013) . Indeed, several studies have found high levels of genetic diversity among wild Ae. tauschii accessions (Wang et al., 2013; Jones et al., 2013) . In order to introduce additional genetic diversity into bread wheat, programmes that recreate the hybridisation process to generate 'synthetic hexaploid wheat' (SHW) have been undertaken at various institutes around the world, including the International Maize and Wheat Improvement Centre (CIMMYT, Mexico), NIAB (UK), and the Commonwealth Scientific and Industrial Research Organisation (CSIRO, Australia). The process involves hybridising T. turgidum spp. durum with Ae. tauschii, followed by rescue of the triploid embryo, and subsequent chromosome doubling using colchicine to generate hexaploid individuals. Careful selection of diverse Ae. tauschii donors can result in SHW accessions that maximise the D genome variation captured, and so increase the potential benefit of SHW in wheat breeding programmes. Ae. tauschii accessions which are low in CD-toxic gliadins could for instance be hybridized with two tetraploid durum wheat landraces that have been shown to possess a relatively low mAb response (van den Broeck, Hongbing, et al., 2010) , to generate a low gluten immunogenic SHW. These SHWs could then be used in pre-breeding programmes for crossing with commercial varieties, combining screening for low gluten immunogenic progeny with the presence of competitive agronomic characters.
Mutation breeding
Mutation breeding is based on the random induction of genomewide mutations, followed by selection of plants carrying mutations in the gene(s) of interest; products of mutation breeding can be released on the market without regulation. The type and frequency of mutations obtained in classical mutagenesis programmes depends on the method used (chemical or ionizing radiation), the type and concentration of mutagen, and the duration of the treatment, which are adjusted on a case by case basis. Polyploid crops in general tolerate higher mutation loads than diploid crops (Shu, Forster, and Nakagawa, 2011; Oladosu et al., 2016) . This is certainly necessary for gliadin mutagenesis in wheat: stacking mutations in multiple gliadin genes into a single plant through crossing is very challenging, due to the number of gliadin genes and their close physical linkage, so this strategy can only be effective if the starting lines already contain many mutated gliadin genes or many gliadins have been deleted from them.
EMS
Ethyl methane sulfonate (EMS) is a chemical mutation approach that primarily results in transitions of G/C to A/T nucleotides in the DNA. In the context of α-gliadin and γ-gliadin genes, EMS treatment may result in mis-sense mutations within epitopes, which could disrupt binding to the Antigen Presenting Cells, or non-sense mutations upstream of the epitopes which truncate the protein or prevent its translation. EMS mutations are detected using an approach termed Targeting Local Lesions IN Genomes (TILLING). Detection of induced mutations originally relied on enzyme-mediated cleavage of mismatched nucleotides (McCallum, Comai, Greene, and Henikoff, 2000) , but is now commonly done by DNA sequencing of either the complete genome or a subset of the genome, either produced with restriction enzymes or using approaches such as exome capture. Acevedo-Garcia et al. (2017) used TILLING to identify missense mutations in each of the three wheat Mildew Locus O (TaMLO) homoeologues, which were subsequently stacked to produce plants with enhanced, yet incomplete, resistance towards powdery mildew (Blumeria graminis f. sp. tritici (Bgt)).
A straightforward screening system for EMS TILLING populations has been constructed in tetraploid (T. turgidum cv. Kronos) and hexaploid (T. aestivum cv. Cadenza) wheat. Both TILLING populations have recently been sequenced using exome capture (Krasileva et al., 2017) , allowing identification of TILLING mutants in target genes via DNA sequence searches of online databases (www.wheat-tilling.com/). Gluten gene mutants can be identified bioinformatically in these populations, but in practice few mutated gliadin genes have been found. The high copy number and sequence similarity make it difficult to correctly assemble gliadin sequences. As a consequence, assembly of sequence reads from a mutated population runs the risk of combining reads with point mutations from multiple genes into single sequence assemblies. If filtered out, this could lead to an artificially low mutation frequency, but if not filtered, it could result in an over-estimation of the average number of mutations per gene. The use of Pacific Bioscience Circular Consensus Sequencing (PacBio CCS), which produces longer sequence reads, may solve some assembly issues. However, the resulting sequence data would likely still need to be combined with more accurate short read sequencing approaches (e.g. Illumina) to compensate for the relatively high PacBio sequencing error rate.
Gamma irradiation
Gamma (γ)-irradiation produces reactive oxygen species (ROS) that cause DNA oxidative damage or DNA single/double strand breaks. Double strand breaks are repaired by the cell's non-homologous end joining (NHEJ) mechanism, which is a relatively error-prone process. Most errors lead to small deletions, although base-pair substitutions, inversions, and small insertions also may be found (Cockram, Mackay, and O'Sullivan, 2007; Morita et al., 2009) . Gamma irradiation therefore has the potential to mutate epitopes, remove whole gliadin genes, or even delete multiple gliadin genes.
In barley, γ-irradiated accession Risø 56 (lacking B-hordeins), Risø 1508 (lacking C-hordeins) and R118 (an Ethiopian derived line which lacks D-hordeins) have been intercrossed to produce an Ultra Low Gluten variety (ULG 2.0) with a reduction of hordein (gluten) content below 5 ppm, thus allowing it to be classified as 'gluten-free' (Tanner, Blundell, Colgrave, and Howitt, 2016) . Subsequent crossing and selection with commercial varieties resulted in a variety with good malting and brewing characteristics (now marketed as 'Kebari'). Interestingly, in several countries the products made with this variety cannot legally be marketed as gluten-free, solely because it contains barley.
In wheat a strategy to introduce similar resources into commercial breeding programmes could be based on screening γ-irradiated hexaploid wheat populations, such as that created in the UK from the commercial cultivar Paragon. We are currently screening these lines for changes in their gluten pattern on acid PAGE protein gels (Cooke, 1995) , prior to further characterisation of a subset of lines using approaches such as RNA-seq, qPCR, and/or proteomics.
Deletion lines
Wheat deletion lines are available in which whole chromosomes, or parts of chromosomes, have been deleted by crossing monosomic with tetrasomic lines, or by introgression of alien addition or translocation lines into cv. 'Chinese Spring' to induce deletions (Endo and Gill, 1996) . A set of these hexaploid wheat cv. 'Chinese Spring' deletion lines has been used to test the effects of individual deletions on the reduction of CD epitopes and on technological properties. A deletion line missing the short arm of chromosome 6D (6DS) in which the 6D α-gliadin locus had been deleted, was found to have strongly decreased mAb responses against Glia-α1 and Glia-α3 epitopes . The absence of these α-gliadin proteins also led to a significant change in dough mixing properties and dough rheology, as the dough became stiffer and less elastic. In contrast, the deletion of the ω-gliadins, γ-gliadins and LMW-glutenin subunits on chromosome 1DS removed some epitopes, but the technological properties were retained (van den Broeck et al., 2009).
A. Jouanin et al. Food Research International xxx (xxxx) xxx-xxx 3.5. Transgenic approaches to reduce CD toxicity Until recently, wheat was considered a challenging crop for genetic transformation; particle bombardment was routinely used for delivery of gene constructs, despite its many drawbacks in the quality of plants generated, which included multiple insertions with complex rearrangements. Furthermore, only a limited range of germplasm could be utilised. The development of supervirulent Agrobacterium tumefaciens strains (Wu, Doherty, and Jones, 2008) , plus changes to media components and the introduction of new techniques (Wu, Sparks, Amoah, and Jones, 2003; Risacher, Craze, Bowden, Paul, and Barsby, 2009 ) improved efficiency. However, the major breakthrough was made by Ishida, Tsunashima, Hiei, and Komari (2014) , using the US soft white wheat, Fielder. This new technology is implemented at NIAB and has been used to both extend the range of UK spring and winter germplasm which can be transformed, and to support a high throughput wheat transformation platform.
3.5.1. Gene silencing using RNA interference RNA interference (RNAi) is a conserved biological process initially identified as a plant defence mechanism, in which a viral doublestranded RNA (dsRNA) is cleaved, silencing viral gene expression and inhibiting further replication (Ratcliff, Harrison, and Baulcombe, 1997) . It has since been demonstrated that genetic transformation of plants with a construct encoding a dsRNA molecule similar to an endogenous plant single-stranded mRNA, triggers silencing of that specific plant gene (Waterhouse and Helliwell, 2003) .
Two research groups have successfully silenced gliadin expression using RNAi. Becker et al. (2012) silenced α-gliadins, eliminating 20 different storage proteins from the grain, whereas Gil-Humanes, Pistón, Tollefsen, Sollid, and Barro (2010) down-regulated gliadins from all groups in bread wheat, with an average reduction of 92.2% in the R5 mAb assay. T cell tests demonstrated a 10-100-fold reduction in DQ2 and DQ8 epitopes from α-gliadins, γ-gliadins and ω-gliadins. Indeed, total gluten extracts of three transgenic wheat lines did not to stimulate T cell clones. Down-regulation of γ-gliadins resulted in an increase of other gluten proteins in the grains (Gil-Humanes et al., 2010) , but little or no effect was found on dough strength or gluten and starch properties (Pistón, Gil-Humanes, Rodríguez-Quijano, and Barro, 2011; Gil-Humanes, Pistón, Giménez, Martín, and Barro, 2012; Gil-Humanes et al., 2014) .
RNAi has also been used to suppress the DEMETER (DME) homoeologues in wheat (Wen et al., 2012) . The DME gene encodes a 5-methylcytosine DNA glycosidase that demethylates the promotor regions of gliadins and LMW-glutenins in the wheat endosperm. This demethylation is essential for activation of the genes during endosperm development. DME RNAi transgenic plants showed a high degree of DME transcript suppression, resulting in > 75% reduction in the amount of immunogenic prolamins.
Providing their agronomic properties and yields are acceptable, such RNAi wheat lines may become candidates for the production of wheat-based products for 'gluten-free' or 'low-in-gluten' diets. However, it should be noted that these strategies require a stable integration of the RNAi cassette into the genome, thus resulting in a genetically modified (GM) plant. It is therefore subject to relevant national and international GM regulations, with the accompanying long, expensive, and uncertain procedure for market approval.
Targeted mutagenesis to generate small indels and to delete genes
In contrast to mutation breeding, genome (gene) editing approaches aim to induce mutations only within specific targets. These methods include Meganucleases, Zincfinger nucleases, TALENs and CRISPRCas9. The regulatory status of plants and plant products derived from gene editing is currently unclear in the European Union (Sprink, Eriksson, Schiemann, and Hartung, 2016) . The current method of choice is CRISPR-Cas9 due to its ease of use (e.g., Schaart, van de Wiel, Lotz, and Smulders, 2016) . The CRISPR-Cas9 system was originally described as a bacterial defence mechanism against viral infections (Barrangou et al., 2007) and has since been customised to induce mutations and deletions at specific locations within a target gene in animals and plants (Belhaj et al., 2013; Zhou, Liu, Weeks, Spalding, and Yang, 2014; Schaart et al., 2016) . Mutations can be induced by introducing a guide RNA (gRNA) complementary to the gene of interest, plus an expression cassette to express the Cas9 endonuclease protein. The 20-mer gRNA directs the Cas9 nuclease to the target site within the gene of interest, where the nuclease generates a double strand DNA break, three bases upstream of a specific protospacer adjacent motif (PAM). In plants, repair by NHEJ can result in insertion/deletions (indels) and other mutations, that can result in beneficial phenotypes (Schaart et al., 2016; van de Wiel et al., 2017) .
CRISPR-Cas9 and other site-directed nucleases have been successfully used to target homeologous genes in diploid and polyploid crops (Brooks, Nekrasov, Lippman, and van Eck, 2014; Lawrenson et al., 2015) . In potato, the four copies of Granule-bound starch synthase (GBSS) have been simultaneously modified to alter starch composition in tetraploid potato (Andersson et al., 2017) . In bread wheat, the TALEN system was used to simultaneously mutate the three homoeologs of an TaMLO gene (Wang et al., 2014) . Using a Cas9/guide ribonucleoprotein complex in plant callus, protoplasts and immature embryos, homeologous genes were successfully edited in hexaploid and durum wheat (Zhang et al., 2016; Liang et al., 2017) . In this system no foreign DNA is added to the plant cell, so plants developed in this manner might not be regulated as GM, as was recently propositioned by the U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) in its proposed revision of regulations (USDA, 2017) .
With these examples, it should also be feasible to modify and/or delete gliadin genes from hexaploid wheat. Such experiments are ongoing at NIAB and elsewhere. In theory, several types of mutations could be generated in the gliadin genes. Small indels, within or upstream of the epitope region, can generate premature stop codons resulting in truncated proteins that lack CD epitopes or within modified epitopes which are no longer immunogenic. Moreover, genes of the α-, γ-and ω-gliadin families are each grouped at single loci on the short arms of the group 6 and 1 chromosomes, respectively. The α-gliadin Gli-2 loci contains α-gliadin interspersed with retrotransposons (Gu et al., 2004) . The γ -gliadin locus also includes other prolamin and nonprolamin genes (Gao et al., 2007) . Cas9-mediated double strand breaks generated simultaneously in at least two gliadin genes on the same chromosome may result in a deletion of the intervening genes. Similarly, multiplexing gRNAs to target different sites within one gliadin gene could, together with a high mutation rate, delete only the immunogenic epitopes from the gliadin protein.
Following wheat transformation with the gliadin gene editing construct, T1 seed could be analysed by Acid-PAGE separation of storage proteins, allowing rapid identification of plants with modified gliadin profiles. Lines of interest could then be further analysed using methods such as deep sequencing of the genome, digital drop real-time PCR to determine gliadin copy number, and RNA-seq of developing grains to determine gene expression profiles. Jouanin et al. (in preparation) are currently using a process termed 'Gluten genes Enrichment and Sequencing' (GlutEnSeq), a protocol based on REnSeq methods (Jupe et al., 2013) . This approach uses exome capture to enrich for gluten gene genomic DNA from lines of interest for targeted re-sequencing, preferably using a long read technology such as PacBio. Proteomics methods such as LC-QTOF-MSMS could be used to generate information on the composition of the gliadins produced in mutant lines, to quantify epitope levels, and to determine the occurrence of amino acid changes in epitope-harbouring peptide fragments.
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Prospects for the low gluten immunogenicity strategies
The food processing and wheat breeding strategies described represent two major routes for the development of cereal products with low gluten immunogenicity. Gluten-free products, made without wheat, barley or rye, are now increasingly found on grocery store shelves. However, these products typically require the inclusion of numerous additives, resulting in products that are often less healthy than gluten-based equivalents. To overcome this issue, other strategies have to be deployed.
Malting may be one of the most applicable methods for large-scale preparation of products with low gluten immunogenicity in the food processing industry, and it can even enhance sourdough fermentation when the malting process is not fully stopped. Similarly, sourdough is a traditional method used to increase loaf volume for bread baking which is possible to implement at industrial scale. Sourdough can also be combined with malting for further reduction of gluten immunogenicity. However, in addition to being more time consuming, sourdough has a taste that may not be widely accepted by consumers.
While the separation of gliadins from glutenins, followed by substitution of gliadins for non-immunogenic oat avenins, is possible at a laboratory scale, large-scale implementation could be challenging and would require considerable infrastructure. From another perspective, the labelling and reduction in the use of vital gluten as an additive, used as source of protein to improve food structure, is a simple approach that would improve the healthiness of gluten-sensitive patients. Unlike GM breeding techniques, most of the candidate food processing techniques for making low gluten-immunogenic products are already implemented, and do not arouse ethical and political issues.
From a wheat breeding perspective, very few polyploid wheat accessions show low gliadin immunogenicity, and those that do lack the agronomic characteristics required for commercial varieties. Introgression of the multiple low immunogenic gliadin loci involved into commercial varieties would be a complex undertaking. Since the expected result would only be a low-immunogenic line, not a CD-safe wheat, it is not anticipated to be a likely near-term target in wheat breeding.
Mutation breeding represents an attractive option to create wheat with low gluten immunogenicity. EMS TILLING on members of large gene families is challenging. Again multiple mutations are necessary, but if these occur in multiple plants then a programme of backcrossing followed by recurrent self-pollination would be required to remove background mutations, while retaining as many homozygous gliadin mutations as possible. However, as the gliadins are closely linked on chromosome 1 and 6, the recombination events required to combine all mutations in a single genetic background might be very rare. Induced mutations using γ-irradiation would be a more tractable approach, since multiple gliadin genes may be removed in single deletion events. This approach has been successfully undertaken in the diploid crop barley, where inter-crossing γ-irradiated lines, each missing a different prolamin gene family, generated an Ultra Low Gluten line that was successfully crossed with commercial varieties (Tanner et al., 2016 ), leading to a commercial variety with < 20 ppm gluten. In theory, this line could be used for breeding more low-gluten barley varieties, although it would represent a major bottleneck for genetic diversity around these deletions. The variety also comes with a yield penalty. It is not expected that this line will be used by other breeders to generate low-gluten barley in the short term (Tanner, pers. comm.) . However, the case for wheat may be stronger, as CD patients encounter wheat gluten in many food products, but can easily avoid barley by drinking only gluten-free beer.
The use of RNAi in wheat has been shown to be very efficient in decreasing the amount of gliadins expressed in the grain, without greatly altering dough properties. Nonetheless, the RNAi construct must be retained in the plant genome, resulting in a GM plant. Multiple factors restrict the commercial feasibility of using GM crops, including the costs of the regulatory process in those countries that allow GM crops (Laursen, 2016) . However, this may not be the case with CRISPRCas9 technology, as after having generated inheritable mutations in target genes, the T-DNA can be crossed out. Whether the resulting products, which do not contain foreign DNA, will be regulated as GM plants, is under debate (Sprink et al., 2016) . In some countries, processbased regulation may define them as GM, whereas other countries with a more product-based approach may consider them to be identical to plants produced by conventional or mutation breeding. The European Food Safety Authority (EFSA) GMO panel (2015) considered the use of site-directed nucleases for inducing small deletions or insertions at a precisely defined location in the genome (SDN-1) as a form of mutagenesis. Acceptance by consumers may also be an issue (Ishii and Araki, 2016) but acceptance of products that are tailored to the needs of specific groups of consumers (e.g., hypoallergenic fruits, nuts etc.) is probably much higher than that of products tailored to the needs of producers or the general public (Schenk et al., 2008; Schenk et al., 2011; Kronberger, Wagner, and Nagata, 2014) .
In the future, low gluten immunogenicity may become one of many traits included in commercial breeding programmes. Achieving low gluten-immunogenic wheat, and ultimately food products, will require a great deal of effort and is likely to require changes in industrial grain and food processing processes. Despite these challenges, the importance of wheat (and other gluten-containing immunogenic grains) in the human diet, along with the increasing worldwide incidence of immunogenic diseases such as CD, means that it is imperative that these challenges are now addressed.
Depicted are simplified food supply chains comprising of two steps, plant breeding and food processing, leading to the final food product. Three variants, a), b) and c), of this food supply chain can be envisaged, depending on the step at which efforts are made to generate gluten-free or coeliac-safe(r) products and whether the process includes wheat ingredients or not. These three variants are presented here in the same order as described in the paper. a) Gluten-free products are generated using substitutions for wheat to avoid the presence of its immunogenic gluten fraction. b) Coeliac-safer of coeliac-safe products could be made at the food-processing step by processing wheat grains to decrease their immunogenic gluten fraction before proceeding to processing of the final product. c) Coeliac-safer or coeliac-safe products could be made based on plant breeding of wheat varieties with reduced immunogenic gluten fraction, used in a standard grain processing and final food product processing. Note that b) and c) can complement each other to achieve a further reduction of gluten immunogenicity.
